Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

A surgical mistake by a Broward bariatric surgeon will cost him time and money — taking continuing medical education courses and $10,000. The mistake cost the patient a kidney and a gallbladder. That ...

Johnson & Johnson gained Inlexzo, formerly known as TAR-200, when it acquired privately held Taris Biomedical in 2019. The deal gave J&J a treatment it says could change way the “non-muscle invasive” ...

An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...